Viewing nowCombinationDual X Tablet 10/160mg
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 201706745 · Approved 2017.08.22 · Insurance code 622802980
Treatment of essential hypertension not controlled by monotherapy
This medicine is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy using Amlodipine or Valsartan. It helps effectively lower blood pressure and reduce cardiovascular risk.
The recommended dose is 1 tablet once daily, taken with water regardless of food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended to adjust the dose using the individual components (amlodipine or valsartan); however, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Use caution when increasing the dose.
Children: Use of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication may cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication's main components or similar drugs, women who are pregnant or breastfeeding, and those with severe kidney or liver disorders should not take this medication. Patients with low sodium or fluid levels in the body may experience low blood pressure; therefore, their condition should be checked before taking this medication, and blood pressure should be closely monitored during treatment. Patients with high potassium levels or those taking medications that may increase potassium levels should have their potassium levels checked frequently. Patients with abnormalities in renal blood vessels or those who have recently undergone kidney transplantation may experience worsened kidney function while taking this medication; hence, careful monitoring is necessary. If symptoms of angioedema occur, the medication should be discontinued immediately and a doctor should be consulted, and it should not be taken again. Patients with heart failure or those after myocardial infarction should carefully assess and monitor kidney function while taking this medication. This medication may cause dizziness or fatigue, hence caution is needed while driving or operating machinery. In case of overdose, low blood pressure or arrhythmias may occur, and immediate medical attention is required. This medication can interact with other blood pressure medications or specific drugs, so patients must inform their doctor or pharmacist of any other medications they are taking. Elderly patients may take the usual dose, but it is important to follow the clinician's instructions depending on their condition. The safety and effectiveness of this medication have not been established for children or adolescents under 18 years of age, and its use is not recommended. Patients with impaired liver function should adjust the dosage of this medication, and those with severe liver impairment should avoid taking it. Possible adverse reactions during treatment include headache, dizziness, swelling, rash, and if severe symptoms occur, immediate consultation with a healthcare professional is advised.
pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbances, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, back pain, arthritis, muscle spasms, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decrease in hemoglobin, decrease in hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, renal impairment, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbances, peripheral neuropathy, hypertonic muscle condition, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitability, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage ensures the safety and effectiveness of the medication.
Bright yellow oval film-coated tablet
28 tablets/PTP[(14 tablets/PTP×2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.